Tag: Polytherapy

According to research presented at the 2025 ASCO Annual Meeting, combination therapy significantly improved overall survival and progression-free survival in patients with advanced non-small cell lung cancer compared to monotherapy. Mastering how to use combination therapy is a critical strategy in pharmacology for enhancing therapeutic efficacy, combating drug resistance, and managing complex conditions.

According to a 2019 study, combination antimicrobial therapy for multidrug-resistant Gram-negative bacteria was associated with lower mortality risk compared to monotherapy. This highlights the critical role of using multiple agents, which is also known by other names, to improve patient outcomes, making **what is another name for combination therapy** a key question in modern medicine.

In the United States, about 30% of older adults take five or more drugs simultaneously, a practice known as polypharmacy. This highlights the prevalence of using multiple medications, a core principle behind the question, **what is combination therapy and how does it work?**

Initial single-drug anti-epileptic therapy is effective for about 60% of patients, leaving many to explore combination treatments [1.7.1]. For those with refractory epilepsy, a key question is: can you take lacosamide and Keppra together for better seizure control?

Approximately one-third of people with epilepsy have drug-resistant seizures, which often necessitates a combination of medications to achieve adequate control. When considering polytherapy, it is crucial for both patients and healthcare providers to understand the specific safety and efficacy profile, which is why the question of 'can you take Keppra and Topamax together?' is a common concern.